{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,24]],"date-time":"2026-01-24T07:24:29Z","timestamp":1769239469956,"version":"3.49.0"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2013,9,22]],"date-time":"2013-09-22T00:00:00Z","timestamp":1379808000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clin Rheumatol"],"published-print":{"date-parts":[[2014,9]]},"DOI":"10.1007\/s10067-013-2387-z","type":"journal-article","created":{"date-parts":[[2013,9,21]],"date-time":"2013-09-21T03:43:13Z","timestamp":1379734993000},"page":"1307-1312","source":"Crossref","is-referenced-by-count":26,"title":["Comparison of tuberculosis incidence in ankylosing spondylitis and rheumatoid arthritis during tumor necrosis factor inhibitor treatment in an intermediate burden area"],"prefix":"10.1007","volume":"33","author":[{"given":"Hye Won","family":"Kim","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jin Kyun","family":"Park","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ji-Ae","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Young Im","family":"Yoon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eun Young","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yeong Wook","family":"Song","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hang Rae","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eun Bong","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2013,9,22]]},"reference":[{"key":"2387_CR1","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1002\/art.1780310302","volume":"31","author":"FC Arnett","year":"1988","unstructured":"Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS et al (1988) The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 31:315\u2013324","journal-title":"Arthritis Rheum"},{"key":"2387_CR2","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/j.jbspin.2010.12.004","volume":"78","author":"L Baronnet","year":"2011","unstructured":"Baronnet L, Barnetche T, Kahn V, Lacoin C, Richez C, Schaeverbeke T (2011) Incidence of tuberculosis in patients with rheumatoid arthritis. A systematic literature review. Joint Bone Spine 78:279\u2013284","journal-title":"Joint Bone Spine"},{"key":"2387_CR3","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1186\/ar592","volume":"4","author":"J Braun","year":"2002","unstructured":"Braun J, Sieper J (2002) Therapy of ankylosing spondylitis and other spondyloarthritides: established medical treatment, anti-TNF-alpha therapy and other novel approaches. Arthritis Res 4:307\u2013321","journal-title":"Arthritis Res"},{"key":"2387_CR4","doi-asserted-by":"crossref","first-page":"3230","DOI":"10.1002\/art.11325","volume":"48","author":"JC Davis","year":"2003","unstructured":"Davis JC, Van Der Heijde D, Braun J, Dougados M, Cush J, Clegg DO et al (2003) Recombinant human tumor necrosis factor receptor (etanercept) for treating ankylosing spondylitis: a randomized, controlled trial. Arthritis Rheum 48:3230\u20133236","journal-title":"Arthritis Rheum"},{"key":"2387_CR5","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1136\/ard.2009.118935","volume":"69","author":"W Dixon","year":"2010","unstructured":"Dixon W, Hyrich K, Watson K, Lunt M, Galloway J, Ustianowski A et al (2010) Drug-specific risk of tuberculosis in patients with rheumatoid arthritis treated with anti-TNF therapy: results from the British Society for Rheumatology Biologics Register (BSRBR). Ann Rheum Dis 69:522\u2013528","journal-title":"Ann Rheum Dis"},{"key":"2387_CR6","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/S0140-6736(08)61000-4","volume":"372","author":"P Emery","year":"2008","unstructured":"Emery P, Breedveld FC, Hall S, Durez P, Chang DJ, Robertson D et al (2008) Comparison of methotrexate monotherapy with a combination of methotrexate and etanercept in active, early, moderate to severe rheumatoid arthritis (COMET): a randomised, double-blind, parallel treatment trial. Lancet 372:375\u2013382","journal-title":"Lancet"},{"key":"2387_CR7","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1038\/nri802","volume":"2","author":"M Feldmann","year":"2002","unstructured":"Feldmann M (2002) Development of anti-TNF therapy for rheumatoid arthritis. Nat Rev Immunol 2:364\u2013371","journal-title":"Nat Rev Immunol"},{"key":"2387_CR8","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1128\/CVI.00221-12","volume":"19","author":"CT Fiske","year":"2012","unstructured":"Fiske CT, de Almeida AS, Shintani AK, Kalams SA, Sterling TR (2012) Abnormal immune responses in persons with previous extrapulmonary tuberculosis in an in vitro model that simulates in vivo infection with Mycobacterium tuberculosis. Clin Vaccine Immunol 19:1142\u20131149","journal-title":"Clin Vaccine Immunol"},{"key":"2387_CR9","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1093\/rheumatology\/keq242","volume":"50","author":"JB Galloway","year":"2011","unstructured":"Galloway JB, Hyrich KL, Mercer LK, Dixon WG, Fu B, Ustianowski AP et al (2011) Anti-TNF therapy is associated with an increased risk of serious infections in patients with rheumatoid arthritis especially in the first 6\u00a0months of treatment: updated results from the British Society for Rheumatology Biologics Register with special emphasis on risks in the elderly. Rheumatology (Oxford) 50:124\u2013131","journal-title":"Rheumatology (Oxford)"},{"key":"2387_CR10","doi-asserted-by":"crossref","first-page":"2122","DOI":"10.1002\/art.11137","volume":"48","author":"JJ G\u00f3mez\u2013Reino","year":"2003","unstructured":"G\u00f3mez\u2013Reino JJ, Carmona L, Valverde VR, Mola EM, Montero MD (2003) Treatment of rheumatoid arthritis with tumor necrosis factor inhibitors may predispose to significant increase in tuberculosis risk: a multicenter active\u2013surveillance report. Arthritis Rheum 48:2122\u20132127","journal-title":"Arthritis Rheum"},{"key":"2387_CR11","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1007\/s10067-007-0741-8","volume":"27","author":"CL Hou","year":"2008","unstructured":"Hou CL, Tsai YC, Chen LC, Huang JL (2008) Tuberculosis infection in patients with systemic lupus erythematosus: pulmonary and extra-pulmonary infection compared. Clin Rheumatol 27:557\u2013563","journal-title":"Clin Rheumatol"},{"key":"2387_CR12","first-page":"1","volume":"18","author":"M Jacobs","year":"2007","unstructured":"Jacobs M, Samarina A, Grivennikov S, Botha T, Allie N, Fremond C et al (2007) Review: reactivation of tuberculosis by tumor necrosis factor neutralization. Eur Cytokine Network 18:1\u20139","journal-title":"Eur Cytokine Network"},{"key":"2387_CR13","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1086\/421499","volume":"39","author":"J Keane","year":"2004","unstructured":"Keane J (2004) Tumor necrosis factor blockers and reactivation of latent tuberculosis. Clin Infect Dis 39:300\u2013302","journal-title":"Clin Infect Dis"},{"key":"2387_CR14","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1056\/NEJMoa011110","volume":"345","author":"J Keane","year":"2001","unstructured":"Keane J, Gershon S, Wise RP, Mirabile-Levens E, Kasznica J, Schwieterman WD et al (2001) Tuberculosis associated with infliximab, a tumor necrosis factor \u03b1-neutralizing agent. N Engl J Med 345:1098\u20131104","journal-title":"N Engl J Med"},{"key":"2387_CR15","doi-asserted-by":"crossref","first-page":"2218","DOI":"10.3899\/jrheum.110373","volume":"38","author":"EM Kim","year":"2011","unstructured":"Kim EM, Uhm WS, Bae SC, Yoo DH, Kim TH (2011) Incidence of tuberculosis among Korean patients with ankylosing spondylitis who are taking tumor necrosis factor blockers. J Rheumatol 38:2218\u20132223","journal-title":"J Rheumatol"},{"key":"2387_CR16","doi-asserted-by":"crossref","first-page":"374","DOI":"10.4046\/trd.2012.72.4.374","volume":"72","author":"H Lee","year":"2012","unstructured":"Lee H, Dockrell HM, Kim DR, Floyd S, Oh SY, Lee JB et al (2012) The current status of BCG vaccination in young children in South Korea. Tuberc Respir Dis 72:374\u2013380","journal-title":"Tuberc Respir Dis"},{"key":"2387_CR17","doi-asserted-by":"crossref","unstructured":"Lee SK, Kim SY, Kim EY, Jung JY, Park MS, Kim YS et al. (2013) Mycobacterial Infections in patients treated with tumor necrosis factor antagonists in South Korea. Lung (in press)","DOI":"10.1007\/s00408-013-9481-5"},{"key":"2387_CR18","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1001\/archinte.167.12.1297","volume":"167","author":"CC Leung","year":"2007","unstructured":"Leung CC, Lam TH, Chan WM, Yew WW, Ho KS, Leung G et al (2007) Lower risk of tuberculosis in obesity. Arch Intern Med 167:1297","journal-title":"Arch Intern Med"},{"key":"2387_CR19","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1080\/030097402317255372","volume":"31","author":"L Mayordomo","year":"2002","unstructured":"Mayordomo L, Marenco JL, Gomez-Mateos J, Rejon E (2002) Pulmonary miliary tuberculosis in a patient with anti-TNF-alpha treatment. Scand J Rheumatol 31:44\u201345","journal-title":"Scand J Rheumatol"},{"key":"2387_CR20","doi-asserted-by":"crossref","first-page":"2205","DOI":"10.1056\/NEJMra1004965","volume":"365","author":"IB McInnes","year":"2011","unstructured":"McInnes IB, Schett G (2011) The pathogenesis of rheumatoid arthritis. N Engl J Med 365:2205\u20132219","journal-title":"N Engl J Med"},{"key":"2387_CR21","doi-asserted-by":"crossref","first-page":"269","DOI":"10.3904\/kjm.2012.82.3.269","volume":"82","author":"JS Park","year":"2012","unstructured":"Park JS (2012) Korean guidelines for the treatment of tuberculosis. Korean J Med 82:269\u2013273","journal-title":"Korean J Med"},{"key":"2387_CR22","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1093\/rheumatology\/41.2.231","volume":"41","author":"PR Querini","year":"2002","unstructured":"Querini PR, Vecellio M, Sabbadini M, Ciboddo G (2002) Miliary tuberculosis after biological therapy for rheumatoid arthritis. Rheumatology 41:231","journal-title":"Rheumatology"},{"key":"2387_CR23","doi-asserted-by":"crossref","first-page":"3432","DOI":"10.1002\/art.20568","volume":"50","author":"EW St Clair","year":"2004","unstructured":"St Clair EW, van der Heijde DM, Smolen JS, Maini RN, Bathon JM, Emery P et al (2004) Combination of infliximab and methotrexate therapy for early rheumatoid arthritis: a randomized, controlled trial. Arthritis Rheum 50:3432\u20133443","journal-title":"Arthritis Rheum"},{"key":"2387_CR24","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1038\/nrrheum.2010.79","volume":"6","author":"LS Tam","year":"2010","unstructured":"Tam LS, Gu J, Yu D (2010) Pathogenesis of ankylosing spondylitis. Nat Rev Rheumatol 6:399\u2013405","journal-title":"Nat Rev Rheumatol"},{"key":"2387_CR25","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1002\/art.20852","volume":"52","author":"D Heijde van der","year":"2005","unstructured":"van der Heijde D, Dijkmans B, Geusens P, Sieper J, DeWoody K, Williamson P et al (2005) Efficacy and safety of infliximab in patients with ankylosing spondylitis: results of a randomized, placebo\u2013controlled trial (ASSERT). Arthritis Rheum 52:582\u2013591","journal-title":"Arthritis Rheum"},{"key":"2387_CR26","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1002\/art.1780270401","volume":"27","author":"S Linden van der","year":"1984","unstructured":"van der Linden S, Valkenburg HA, Cats A (1984) Evaluation of diagnostic criteria for ankylosing spondylitis. A proposal for modification of the New York criteria. Arthritis Rheum 27:361\u2013368","journal-title":"Arthritis Rheum"},{"key":"2387_CR27","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1086\/383317","volume":"38","author":"R Wallis","year":"2004","unstructured":"Wallis R, Broder M, Wong J, Hanson M, Beenhouwer D (2004) Granulomatous infectious diseases associated with tumor necrosis factor antagonists. Clin Infect Dis 38:1261\u20131265","journal-title":"Clin Infect Dis"},{"key":"2387_CR28","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/0002-9343(85)90034-8","volume":"79","author":"MR Weir","year":"1985","unstructured":"Weir MR, Thornton GF (1985) Extrapulmonary tuberculosis. Experience of a community hospital and review of the literature. Am J Med 79:467\u2013478","journal-title":"Am J Med"},{"key":"2387_CR29","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1002\/art.21734","volume":"54","author":"R Westhovens","year":"2006","unstructured":"Westhovens R, Yocum D, Han J, Berman A, Strusberg I, Geusens P et al (2006) The safety of infliximab, combined with background treatments, among patients with rheumatoid arthritis and various comorbidities: a large, randomized, placebo\u2013controlled trial. Arthritis Rheum 54:1075\u20131086","journal-title":"Arthritis Rheum"}],"container-title":["Clinical Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-013-2387-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10067-013-2387-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-013-2387-z","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,29]],"date-time":"2019-05-29T04:57:28Z","timestamp":1559105848000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10067-013-2387-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,9,22]]},"references-count":29,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2014,9]]}},"alternative-id":["2387"],"URL":"https:\/\/doi.org\/10.1007\/s10067-013-2387-z","relation":{},"ISSN":["0770-3198","1434-9949"],"issn-type":[{"value":"0770-3198","type":"print"},{"value":"1434-9949","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,9,22]]}}}